Cargando…
Afatinib circumvents multidrug resistance via dually inhibiting ATP binding cassette subfamily G member 2 in vitro and in vivo
Multidrug resistance (MDR) to chemotherapeutic drugs is a formidable barrier to the success of cancer chemotherapy. Expressions of ATP-binding cassette (ABC) transporters contribute to clinical MDR phenotype. In this study, we found that afatinib, a small molecule tyrosine kinase inhibitor (TKI) tar...
Autores principales: | Wang, Xiao-kun, Kin Wah To, Kenneth, Huang, Li-yan, Xu, Jing-hong, Yang, Ke, Wang, Fang, Huang, Zhen-cong, Ye, Sheng, Fu, Li-wu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322967/ https://www.ncbi.nlm.nih.gov/pubmed/25436978 |
Ejemplares similares
-
Afatinib reverses multidrug resistance in ovarian cancer via dually inhibiting ATP binding cassette subfamily B member 1
por: Wang, Sheng-qi, et al.
Publicado: (2015) -
Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance
por: KATHAWALA, RISHIL J., et al.
Publicado: (2014) -
Molecular evolution of the ATP-binding cassette subfamily G member 2 gene subfamily and its paralogs in birds
por: Ma, Shengchao, et al.
Publicado: (2020) -
Olmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATP-binding cassette subfamily G member 2 in vitro and in vivo
por: Zhang, Zhiqiang, et al.
Publicado: (2018) -
Regulation of ATP‐binding cassette subfamily B member 1 by Snail contributes to chemoresistance in colorectal cancer
por: Wang, Hao, et al.
Publicado: (2019)